Long-Term Outcomes of the Maze Procedure Combined with Endoatriectomy for Patients with Calcified Left Atria

Yochun Jung1, Kyo Seon Lee1, Sang Gi Oh1

  • 1Department of Thoracic and Cardiovascular Surgery, Chonnam National University Hospital, Chonnam National University School of Medicine, Gwangju, Republic of Korea.

Insights

Left atrial calcification (LAC) impacts maze procedure outcomes. Limited LAC shows better long-term rhythm control after endoatriectomy and maze surgery, suggesting feasibility in select patients.

Area of Science:

  • Cardiology
  • Cardiac Surgery

Background:

  • Left atrial calcification (LAC) is common in rheumatic valvular disease and strongly associated with atrial fibrillation (AF).
  • Endoatriectomy is necessary during the maze procedure for patients with LAC, but its feasibility and outcomes are not well-established.

Purpose of the Study:

  • To evaluate the technical feasibility and long-term outcomes of the maze procedure combined with endoatriectomy in patients with left atrial calcification.
  • To assess the impact of LAC extent on rhythm control and recurrence of AF post-surgery.

Main Methods:

  • Retrospective analysis of 18 patients undergoing combined endoatriectomy and maze procedure.
  • Patients were categorized into "broad" (LAC > 50% of left atrium) and "limited" (LAC ≤ 50%) groups.
  • Follow-up included rhythm assessment via electrocardiography and AF recurrence rates.

Main Results:

  • One operative death occurred due to sepsis.
  • No significant difference in postoperative complications between broad and limited LAC groups.
  • At 11.4 years median follow-up, AF recurred in 11 patients.
  • Significantly fewer patients in the broad LAC group maintained sinus rhythm (P=0.03).
  • 10-year AF recurrence-free survival was 13.9% for broad LAC vs. 66.7% for limited LAC (P=0.01).

Conclusions:

  • The maze procedure with endoatriectomy is technically feasible in patients with LAC.
  • Limited LAC extent is associated with acceptable long-term rhythm outcomes.
  • Extensive LAC may predict poorer long-term rhythm control after the maze procedure.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
20
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
29
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
21
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
27
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
15